Topical dorzolamide and metabolic acidosis in a neonate [10]

British Journal of Ophthalmology

Volumn 87, Issue 8, 2003, Pages 1052-1053

  Morris, S ^a,b   Geh, V ^a,b   Nischal, Ken K ^a,b   Sahi, S ^c   Ahmed, M A S ^c  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c KING GEORGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BICARBONATE; CARBONATE DEHYDRATASE INHIBITOR; CEFOTAXIME; DORZOLAMIDE; FLUCLOXACILLIN; SUCCIMER;

APGAR SCORE; BLOOD PH; CASE REPORT; CLINICAL FEATURE; CORNEA OPACITY; DRUG TOLERABILITY; ECHOGRAPHY; FEEDING BEHAVIOR; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; LETTER; MALE; METABOLIC ACIDOSIS; NEWBORN; PETERS ANOMALY; PRIORITY JOURNAL;

ACIDOSIS; ANTIHYPERTENSIVE AGENTS; CARBONIC ANHYDRASE INHIBITORS; HUMANS; INFANT, NEWBORN; MALE; SULFONAMIDES; THIOPHENES;

EID: 0042205440     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.8.1052     Document Type: Letter

References (6)

1. Portellos M, Buckley EG, Freedman SF. Topical versus oral carbonic anhydrase inhibitor therapy for pediatric glaucoma. J AAPOS 1998:243-7.
2. DeLuise VP, Anderson DR. Primary infantile glaucoma (congenital glaucoma). Review. Surv Ophthalmol 1983;28:1-19.
3. Sugrue MF. Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors. Progr Ret Eye Res 2000;19:87-112.
4. Strahlman E, Tipping R, Vogel R. The Dorzolomide Dose-response Study Group. A six-week dose-response study of the ocular hypotensive effect of dorzolamide with a one-year extension. Am J Ophthalmol 1996;122:183-94.
5. Biollaz J, Munafo A, Buclin T, et al. Whole-blood pharmacokinetics and metabolic effects of the topical carbonic anhydrase inhibitor dorzolamide. Eur J Clin Pharmacol 1995;47:453-60.
6. Adamsons I, Clineschmidt C, Polis A, et al. The Additivity Study Group. The efficacy and safety of dorzolomide as adjunctive therapy to timolol maleate gellan solution in patients with elevated intraocular pressure. J Glaucoma 1998;7:253-60.